4.4 Article

Synthesis of (±)-cis-1-Aryl-3-oxo-2,3-dihydro-1H-benzo[f]chromene-2-carbonitriles and (±)-trans-4-Aryl-2-oxo-3,4-dihydro-2H-benzo[h]chromene-3-carbonitriles

期刊

CHEMISTRYSELECT
卷 4, 期 44, 页码 12902-12905

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/slct.201903982

关键词

Cyanides; density functional calculations; diastereoselectivity; formic acid; oxygen heterocycles

向作者/读者索取更多资源

The unexpected stereospecific synthesis of (+/-)-cis-1-aryl-3-oxo-2,3-dihydro-1H-benzo[f]chromene-2-carbonitriles (2) and (+/-)-trans-4-aryl-2-oxo-3,4-dihydro-2H-benzo[h]chromene-3-carbonitriles (4) from (+/-)-3-amino-1-aryl-1H-benzo[f]chromene-2-carbonitriles (1) and (+/-)-2-amino-4-aryl-4H-benzo[h]chromene-3-carbonitriles (3), respectively, by reacting them in formic acid (88%), at reflux, is reported. A DFT analysis has been applied with success to justify these highly stereospecific reactions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Synthesis and Pharmacological Evaluation of New N-Sulfonylureasas NLRP3 Inflammasome Inhibitors: Identification of a HitCompound to Treat Gout

Paloma Narros-Fernandez, Mourad Chioua, Sonia A. Petcu, Daniel Diez-Iriepa, Laura Cerrada-Galvez, Celine Decouty-Perez, Alejandra Palomino-Antolin, Eva Ramos, Victor Farre-Alins, Ana Belen Lopez-Rodriguez, Alejandro Romero, Jose Marco-Contelles, Javier Egea

Summary: NLRP3 plays a role in various inflammatory diseases, making the development of NLRP3 inflammasome small inhibitors a current area of interest. New N-sulfonylureas were obtained by modifying a previously described NLRP3 inhibitor, MCC950, and these derivatives showed potent inhibitory effects on IL-1 beta release. Compound 4b exhibited the greatest effect, similar to MCC950, and also showed a reduction in caspase-1 activation and IL-1 beta processing. In silico predictions confirmed the safety profile of compound 4b, and in vitro and in vivo studies further supported its anti-inflammatory properties.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Synthesis and Antioxidant Properties of HeteroBisNitrones Derived from Benzene Dicarbaldehydes

Daniel Diez-Iriepa, Isabel Iriepa, Francisco Lopez-Munoz, Jose Marco-Contelles, Dimitra Hadjipavlou-Litina

Summary: This study reports the synthesis and evaluation of nine novel heterobisnitrones as antioxidants, with hBN9 showing the highest activity. The results suggest that hBN9 may be a potent antioxidant with potential anti-inflammatory effects.

ANTIOXIDANTS (2022)

Review Chemistry, Medicinal

Multicomponent reactions as a privileged tool for multitarget-directed ligand strategies in Alzheimer's disease therapy

Sylvain Grosjean, Irene Pachon-Angona, Michella Dawra, Bernard Refouvelet, Lhassane Ismaili

Summary: Alzheimer's disease is a common neurodegenerative disease in the older population, and the use of multitarget-directed ligand strategy can lead to the development of complex molecules with multiple pharmacophores as a treatment approach.

FUTURE MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases

Oscar M. Bautista-Aguilera, Jose M. Alonso, Marco Catto, Isabel Iriepa, Damijan Knez, Stanislav Gobec, Jose Marco-Contelles

Summary: Alzheimer's disease (AD) is a complex disorder characterized by impaired neurotransmission, protein misfolding, and oxidative stress. Compound 4, a N-hydroxy-N-propargylamide hybrid, shows potential as a multifunctional ligand for AD treatment with inhibitory activity, radical scavenging ability, and copper chelation.

MOLECULES (2022)

Editorial Material Chemistry, Multidisciplinary

Editorial: Advances in drug discovery for anti-Alzheimer's agents

Lhassane Ismaili

FRONTIERS IN CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment

Daniel Diez-Iriepa, Damijan Knez, Stanislav Gobec, Isabel Iriepa, Cristobal de los Rios, Isaac Bravo, Francisco Lopez-Munoz, Jose Marco-Contelles, Dimitra Hadjipavlou-Litina

Summary: Novel polyfunctionalized nitrones show potential antioxidant and neuroprotective properties in stroke treatment, with compound (Z)-N-benzyl-1-(2-(3-(piperidin-1-yl)propoxy)phenyl)methanimine oxide exhibiting significant antioxidant and neuroprotective activities.

ANTIOXIDANTS (2022)

Article Biochemistry & Molecular Biology

Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties

Emna Choura, Fares Elghali, Paul J. Bernard, Dhouha Msalbi, Jose Marco-Contelles, Sami Aifa, Lhassane Ismaili, Fakher Chabchoub

Summary: Ten new compounds were synthesized using a simple and cost-efficient method. These compounds exhibited antiproliferative activity in two colorectal cancer cell lines.

MOLECULES (2022)

Article Multidisciplinary Sciences

Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro

Sebastien Pasquereau, Mathilde Galais, Maxime Bellefroid, Irene Pachon Angona, Stephanie Morot-Bizot, Lhassane Ismaili, Carine Van Lint, Georges Herbein

Summary: In this study, several compounds were tested for their antiviral activity against coronaviruses, and one compound, FAD LIJ2P40, showed low cytotoxicity and significant reduction in viral titer of SARS-CoV-2, which opens up the possibility for further evaluation as a potential treatment for Covid-19.

SCIENTIFIC REPORTS (2022)

Article Biochemistry & Molecular Biology

Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment

Imen Dakhlaoui, Paul J. Bernard, Diana Pietrzak, Alexey Simakov, Maciej Maj, Bernard Refouvelet, Arnaud Beduneau, Raphael Cornu, Krzysztof Jozwiak, Fakher Chabchoub, Isabel Iriepa, Helene Martin, Jose Marco-Contelles, Lhassane Ismaili

Summary: Alzheimer's disease (AD) is a complex neurodegenerative disease without a cure, causing significant social and economic impact. Multitarget-directed ligands (MTDLs) may provide a promising therapeutic strategy for AD treatment. In this study, novel MTDLs were designed and synthesized using simple and cost-efficient methods, targeting calcium channel blockade, cholinesterase inhibition, and antioxidant activity. Two sulfonamide-dihydropyridine hybrids were identified to possess cholinesterase inhibition, calcium channel blockade, antioxidant capacity, and Nrf2-ARE activating effect, suggesting their potential for further investigation in AD therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Physical

Synthesis of N-Substituted Pyrroles Catalyzed by Low-Cost and Commercially Available Aluminas

Omar Portilla-Zuniga, Oscar M. Bautista-Aguilera, Jose J. Martinez, Hugo Rojas, Mario A. Macias, Isabel Iriepa, Adrian Perez-Redondo, Angel Sathicq, Juan-Carlos Castillo, Gustavo P. Romanelli

Summary: The Paal-Knorr reaction of acetonylacetone with primary amines catalyzed by CATAPAL 200 under conventional heating at 60 degrees C for 45 min resulted in N-substituted pyrroles in yields of 68-97%. CATAPAL 200, with its high percentage of Bronsted-Lewis acid sites (23%) and pore diameter (37.8 nm), promotes the formation of pyrrole ring by facilitating condensation and dehydration processes. This protocol offers simplicity, high yields, reduced reaction time, solvent-free conditions, stoichiometric amounts of reactants, low catalyst loading, and clean reaction profile. Furthermore, CATAPAL 200 is inexpensive and readily available, making it a cost-effective option for chemical transformations. The catalyst can be reused for up to five cycles without significant loss of catalytic activity, making this protocol sustainable and advantageous compared to conventional methods.

CATALYSTS (2023)

Article Pharmacology & Pharmacy

Calcium channel blockers' contribution to overcoming Current drug discovery challenges in Alzheimer's disease

Paul J. Bernard, Djamila Bellili, Lhassane Ismaili

Summary: This article introduces the characteristics of Alzheimer's disease and the challenges in the development of therapeutic drugs, and proposes a polypharmacological approach based on calcium channel blockers as a feasible option.

EXPERT OPINION ON DRUG DISCOVERY (2023)

Article Biochemistry & Molecular Biology

The Proof-of-Concept of MBA121, a Tacrine-Ferulic Acid Hybrid, for Alzheimer's Disease Therapy

Emelina R. Rodriguez-Ruiz, Raquel Herrero-Labrador, Ana P. Fernandez-Fernandez, Julia Serrano-Masa, Jose A. Martinez-Montero, Daniel Gonzalez-Nieto, Mayuri Hana-Vaish, Mohamed Benchekroun, Lhassane Ismaili, Jose Marco-Contelles, Ricardo Martinez-Murillo

Summary: We describe a compound called MBA121, which is a tacrine-ferulic acid hybrid designed for the treatment of Alzheimer's disease (AD). MBA121 shows good anti-aggregation properties, selective inhibition of butyrylcholinesterase, neuroprotection against toxic insults, and promising ADMET properties. In animal experiments, MBA121 significantly reduced learning deficits and Aβ plaque burden, demonstrating its potential as a therapeutic agent for AD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents

Tim Keuler, Carina Lemke, Paul W. Elsinghorst, Isabel Iriepa, Mourad Chioua, Maria Angeles Martinez-Grau, Christopher D. Beadle, Tatiana Vetman, Francisco Lopez-Munoz, Timo Wille, Ulrike Bartz, Winnie Deuther-Conrad, Jose Marco-Contelles, Michael Guetschow

Summary: The multifactorial nature of Alzheimer's disease requires the development of drugs that can target different relevant pathways. In this study, we synthesized a series of tailored chromanones and identified compound 19 as a representative compound with balanced pharmacological properties. Compound 19 showed inhibitory activities against human acetyl- and butyrylcholinesterase, monoamine oxidase-B, and high affinity to sigma 1 and sigma 2 receptors.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)

Article Chemistry, Medicinal

The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents

Tim Keuler, Carina Lemke, Paul W. Elsinghorst, Isabel Iriepa, Mourad Chioua, Maria Angeles Martinez-Grau, Christopher D. Beadle, Tatiana Vetman, Francisco Lopez-Munoz, Timo Wille, Ulrike Bartz, Winnie Deuther-Conrad, Jose Marco-Contelles, Michael Gutschow

Summary: The multifactorial nature of Alzheimer's disease necessitates the development of agents that can target multiple relevant pathways. In this study, we synthesized a series of tailored chromanones and evaluated their biological activities. One representative compound (compound 19) was identified, which exhibited balanced pharmacological properties and showed inhibitory activities against acetylcholinesterase, butyrylcholinesterase, monoamine oxidase-B, and high affinity to sigma 1 and sigma 2 receptors. Our findings provide a framework for the development of chromanone-based multineurotarget agents.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)

暂无数据